How to Pull Off a Company Rebrand in the IT Industry

 

Few industries change as rapidly as the tech industry. With ever-evolving telecommunications and tech innovations pushing change, tech companies must be prepped to turn on a dime and meet the demands of their customers wanting the stay on the leading edge. So how does an IT company brand itself to be relevant now, and well into the future where the tech landscape may look different? We answer this question today talking with Amber Lawhun, VP of Marketing & Partner Programs for Pinnacle Business Systems.

When Pinnacle began 30 years ago, it was an IBM-only solution for companies. But at the time, this is what businesses needed. Over the course of three decades and the rapid evolution of tech, businesses have grown new demands. Now, clients come to Pinnacle looking for a full-scale solution to their IT needs: Security, speed, and a comprehensive solution centered around their business outcomes. Pinnacle has stayed relevant by listening to its customers’ needs and catering its services to meet those new demands.

As Pinnacle rounded its 30 year anniversary, it needed a facelift to reflect the new services it provided, and a tag line that highlighted their core principle and the key to their evergreen success–“Attention you deserve.” This tag line embodies the company’s main feature–a keen ear for listening to its client’s needs. Over the years, Pinnacle has remained agile to the needs of its customer base and has put proven solutions in front of them based on their needs.

Amber attributes the key to their success to their ability to listen, as well as staying authentic and true to its client base. “Customers are looking for trust,” she said, and prefer “substance over flash.” As a successful, long-standing IT company, Amber’s advice to other IT companies navigating a rapidly changing marketplace is simply this: “Bring value and listen to the customer’s needs.”

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @TechMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More